Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of topical omiganan gel in severe papulopustular rosacea
NL-OMON42482Phase 3Not yet recruiting
- Sponsor
- Biofrontera
- Start
- Dec 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in papulopustular rosacea and rosacea comparing Omiganan topical gel with Vehicle topical gel (2 arms). Primary endpoints: Absolute change in inflammatory lesion count, IGA 2-grade reduction and 1 more. Planned start Dec 2015; status: not yet recruiting.
02
Drugs
omiganan
03
Conditions
papulopustular rosacearosacea
Beyond the preview
Go deeper on NL-OMON42482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42482.